Lawrence Berkeley National Laboratory, Berkeley, California 94720, and
Helen Wills Neuroscience Institute, University of California Berkeley, Berkeley, California 94720.
J Neurosci. 2019 Apr 3;39(14):2735-2744. doi: 10.1523/JNEUROSCI.2382-18.2019. Epub 2019 Feb 8.
Trait anxiety has been associated with altered activity within corticolimbic pathways connecting the amygdala and rostral anterior cingulate cortex (rACC), which receive rich dopaminergic input. Though the popular culture uses the term "chemical imbalance" to describe the pathophysiology of psychiatric conditions such as anxiety disorders, we know little about how individual differences in human dopamine neurochemistry are related to variation in anxiety and activity within corticolimbic circuits. We addressed this issue by examining interindividual variability in dopamine release at rest using [C]raclopride positron emission tomography (PET), functional connectivity between amygdala and rACC using resting-state functional magnetic resonance imaging (fMRI), and trait anxiety measures in healthy adult male and female humans. To measure endogenous dopamine release, we collected two [C]raclopride PET scans per participant. We contrasted baseline [C]raclopride D2/3 receptor binding and D2/3 receptor binding following oral methylphenidate administration. Methylphenidate blocks the dopamine transporter, which increases extracellular dopamine and leads to reduced [C]raclopride D2/3 receptor binding via competitive displacement. We found that individuals with higher dopamine release in the amygdala and rACC self-reported lower trait anxiety. Lower trait anxiety was also associated with reduced rACC-amygdala functional connectivity at baseline. Further, functional connectivity showed a modest negative relationship with dopamine release such that reduced rACC-amygdala functional connectivity was accompanied by higher levels of dopamine release in these regions. Together, these findings contribute to hypodopaminergic models of anxiety and support the utility of combining fMRI and PET measures of neurochemical function to advance our understanding of basic affective processes in humans. It is common wisdom that individuals vary in their baseline levels of anxiety. We all have a friend or colleague we know to be more "tightly wound" than others, or, perhaps, we are the ones marveling at others' ability to "just go with the flow." Although such observations about individual differences within nonclinical populations are commonplace, the neural mechanisms underlying normal variation in trait anxiety have not been established. Using multimodal brain imaging in humans, this study takes initial steps in linking intrinsic measures of neuromodulator release and functional connectivity within regions implicated in anxiety disorders. Our findings suggest that in healthy adults, higher levels of trait anxiety may arise, at least in part, from reduced dopamine neurotransmission.
特质焦虑与连接杏仁核和额前扣带回皮质(rACC)的皮质边缘通路的活动改变有关,这些通路接收丰富的多巴胺能输入。尽管流行文化用“化学失衡”一词来描述焦虑症等精神疾病的病理生理学,但我们对人类多巴胺神经化学的个体差异如何与焦虑和皮质边缘回路活动的变化有关知之甚少。我们通过使用[C]raclopride 正电子发射断层扫描(PET)在休息时检查多巴胺释放的个体间可变性,使用静息状态功能磁共振成像(fMRI)检查杏仁核和 rACC 之间的功能连接,以及健康成年男性和女性的特质焦虑测量来解决这个问题。为了测量内源性多巴胺释放,我们为每个参与者收集了两次[C]raclopride PET 扫描。我们对比了基线[C]raclopride D2/3 受体结合和口服哌甲酯给药后的 D2/3 受体结合。哌甲酯阻断多巴胺转运体,增加细胞外多巴胺,并通过竞争性置换导致[C]raclopride D2/3 受体结合减少。我们发现,杏仁核和 rACC 中多巴胺释放较高的个体报告的特质焦虑较低。较低的特质焦虑也与基线时 rACC-杏仁核功能连接减少有关。此外,功能连接与多巴胺释放呈适度负相关,因此 rACC-杏仁核功能连接减少伴随着这些区域多巴胺释放水平升高。总之,这些发现为焦虑的低多巴胺能模型做出了贡献,并支持将 fMRI 和 PET 神经化学功能测量相结合,以推进我们对人类基本情感过程的理解。人们普遍认为,个体在焦虑的基线水平上存在差异。我们都有一个朋友或同事,我们知道他们比其他人更“紧张”,或者,也许我们是那些惊叹于别人“随波逐流”的能力的人。尽管在非临床人群中对个体差异的这种观察很常见,但特质焦虑正常变化的神经机制尚未确定。本研究使用人类多模态脑成像,在将焦虑症相关区域的内在神经调节剂释放和功能连接的固有测量联系起来方面迈出了初步的一步。我们的发现表明,在健康成年人中,较高的特质焦虑水平可能至少部分源于多巴胺神经传递的减少。